Quest PharmaTech Announces New CEO Effective November 2026
Quest PharmaTech (TSXV:QPT) has announced that Madi Madiyalakan will retire as Chief Executive Officer effective November 23, 2026. Jeffrey Shon, a current director of the company, is set to take over as CEO following this transition. The leadership change comes after several years under Madiyalakan's tenure and marks an important strategic shift for Quest PharmaTech. The board has expressed confidence in Shon’s ability to lead the firm into its next phase of growth. No immediate financial impact was disclosed, but investors are likely monitoring how the new CEO will shape future operations. The company is a publicly traded entity on the TSX Venture Exchange and operates within the pharmaceutical technology sector.
Topics: CEO change executive transition